BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38180302)

  • 1. Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A-NRF2-dependent manner.
    Pang P; Zhang S; Fan X; Zhang S
    Cell Biol Int; 2024 Apr; 48(4):431-439. PubMed ID: 38180302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
    Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
    Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.
    Geng Y; Long X; Zhang Y; Wang Y; You G; Guo W; Zhuang G; Zhang Y; Cheng X; Yuan Z; Zan J
    J Transl Med; 2023 Sep; 21(1):652. PubMed ID: 37737187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.
    Hou L; Li S; Li S; Wang R; Zhao M; Liu X
    J Physiol Biochem; 2023 Feb; 79(1):133-146. PubMed ID: 36327034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icariside II suppresses ferroptosis to protect against MPP
    Fan W; Zhou J
    Chin J Physiol; 2023; 66(6):437-445. PubMed ID: 38149556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early B Cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: An experimental study.
    Hu W; Wang M; Sun G; Zhang L; Lu H
    Cell Signal; 2024 Jun; 118():111139. PubMed ID: 38479556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Effects of Querectin against MPP
    Jiang Y; Xie G; Alimujiang A; Xie H; Yang W; Yin F; Huang D
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):42. PubMed ID: 37005755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson's Disease.
    Shen J; Chen S; Li X; Wu L; Mao X; Jiang J; Zhu D
    Neurochem Res; 2024 May; 49(5):1291-1305. PubMed ID: 38424396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
    Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Lipoic acid alleviates ferroptosis in the MPP
    Liu L; Yang S; Wang H
    Cell Biol Int; 2021 Feb; 45(2):422-431. PubMed ID: 33241887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4.
    Wang Z; Li H; Cai H; Liang J; Jiang Y; Song F; Hou C; Hou J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO facilitates cancer metastasis by modifying the m
    Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
    Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Ji FH; Fu XH; Li GQ; He Q; Qiu XG
    Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress-mediated activation of FTO exacerbates impairment of the epithelial barrier by up-regulating IKBKB via N6-methyladenosine-dependent mRNA stability in asthmatic mice exposed to PM2.5.
    Xiong A; He X; Liu S; Ran Q; Zhang L; Wang J; Jiang M; Niu B; Xiong Y; Li G
    Ecotoxicol Environ Saf; 2024 Mar; 272():116067. PubMed ID: 38325270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.
    Jiang T; Xiao Y; Zhou J; Luo Z; Yu L; Liao Q; Liu S; Qi X; Zhang H; Hou M; Miao W; Batsaikhan B; Damba T; Liang Y; Li Y; Zhou L
    Redox Biol; 2023 Dec; 68():102963. PubMed ID: 37984229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
    Azzam SK; Alsafar H; Sajini AA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression.
    Qiao Y; Su M; Zhao H; Liu H; Wang C; Dai X; Liu L; Liu G; Sun H; Sun M; Wang J; Li Z; Fan J; Zhang Q; Li C; Situ F; Xue J; Jia Z; Zhang C; Zhang S; Shan C
    J Exp Clin Cancer Res; 2024 Apr; 43(1):108. PubMed ID: 38600610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.